Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Adenocarcinoma Non-resectable

Clinical trial condition

Pancreatic Adenocarcinoma Non-resectable

Explore clinical trials studying Pancreatic Adenocarcinoma Non-resectable. Study availability and eligibility vary by location and protocol.

8 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma Non-resectable trial results

Recruiting

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

NCT07481383

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Michigan Health Ann Arbor, Michigan, United States

West Virginia University Morgantown, West Virginia, United States

View Trial Details

Recruiting

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

NCT05524090

Conditions: Chemotherapy Effect, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Amsterdam UMC, locatie AMC Amsterdam, North Holland, Netherlands

View Trial Details

Completed

EUS-Guided Cryothermal Ablation in Patients With Stage III Pancreatic Adenocarcinoma (HybridTherm Study)

NCT02336672

Conditions: Pancreatic Adenocarcinoma Non-resectable
Locations: Ospedale San Raffaele Irccs Milan, MI, Italy

View Trial Details

Completed

EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

NCT03772756

Conditions: Pancreatic Adenocarcinoma Non-resectable
Locations: Jianfeng Yang Hangzhou, Zhejiang, China

Hangzhou First People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Completed

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

NCT01053013

Conditions: Colorectal Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Non-resectable
Locations: Weill Cornell Medical Center / The Rogosin Institute New York, United States

View Trial Details

Completed

A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma

NCT01677962

Conditions: Pancreatic Adenocarcinoma Non-resectable
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Active, Not Recruiting

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

NCT06090916

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

FAZA PET/MRI Pancreas

NCT04395469

Conditions: Hypoxia, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Non-resectable, +4 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details